A discussion about how dementias care will change in the future including virtual memory clinics, virtual cognitive stimulation therapy groups, and the use of artificial intelligence.
Agenda
15.10-15.40 | 'In Conversation With' Professor Nick Fox
15.40-16.10 | Can we really slow down the progression of Alzheimer's disease? Dr Naji Tabet
16.25-16.55 | Types of dementia - Dr Richard Perry
16.55-17.15 | ROCHE | The utility of ALZ biomarkers in clinical routine - Dr Femke Bouwmann
17.15-18.15 | What will be the impact of Covid-19 on the future of dementia care?
18.15-18.45 | Summary of the latest research in imaging - Professor Clare MacKay
Presenters
Professor Aimee Spector
Professor of Old Age Clinical Psychiatrist, University College London
Aimee's research broadly focuses on the development and evaluation of psychosocial interventions and outcome measures for people with dementia. For her PhD, she developed and evaluated a novel treatment for dementia called cognitive stimulation therapy (CST), which is now recommended by UK government guidelines (NICE, 2018) and is the primary psychosocial intervention offered by UK memory clinics.
Her recent research has taken a more global focus, for example she leads an MRC funded implementation trial of CST in Brazil, India and Tanzania; and works closely with colleagues from Hong Kong University (through a formal strategic partnership), where we have looked at neuropsychological mechanisms of CST through neuroimaging.
Other intervention research has included evaluation of cognitive behaviour therapy (CBT), mindfulness and compassion focused therapy to manage mood problems in dementia, as well as several training programmes for dementia care staff. She has developed and published a range of outcome measures including measures of dementia knowledge, sense of competence, hope and resilience, and independence and engagement.
Professor Ramin Nilforooshan
Consultant Psychiatrist, Surrey and Borders Partnership NHS Foundation Trust
Prof Ramin Nilforooshan is Consultant Psychiatrist at Surrey and Borders Partnership and Visiting Professor at the University of Surrey (23 publications since 2011). In addition, he is the Associate Medical Director for tge Research & Development; a role which involves safety and accuracy of clinical trials and is also the Dementia Speciality Lead at Kent, Surrey and Sussex.
His main research is on using IoT (Internet of Things) and AI (Artificial Intelligence) technology for dementia care. He is the recipient of numerous HSJ awards and £6.7M funding from NHS England, Innovate UK, the EU and other funders. He is the Principal Investigator and Chief Investigator for a number of national and international clinical trials and has considerable experience running clinical trials.
Dr Raja Badrakalimuthu
Associate Medical Director of Surrey and Borders Partnership NHS Foundation Trust
Dr Raja Badrakalimuthu is a consultant old age psychiatrist and associate medical director at Surrey & Borders Partnership NHS Foundation Trust. His care home service was awarded RCPsych Annual Award for the best OA services last year. He completed masters in neuroscience and medical education. He is a published author and his fictional book A Way with the Fairies deals with an eight-year-old whose father is diagnosed with dementia. He is interested in service development and medical education having previously been involved in setting up liaison service and simulation training. His other interests include history of medicine.